Insulet
PODD
#1133
Rank
S$21.60 B
Marketcap
$308.15
Share price
-0.46%
Change (1 day)
36.85%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.33

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.24. In 2022 the company made an earnings per share (EPS) of $0.09118 a decrease over its 2021 EPS that were of $0.30.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.332450.57%
2022$0.09118-69.57%
2021$0.30109.09%
2020$0.14-38.89%
2019$0.23200%
2018$0.07815-113.04%
2017-$0.60-9.8%
2016-$0.66-60.77%
2015-$1.6939.78%
2014-$1.2112.05%
2013-$1.08-23.15%
2012-$1.4110.2%
2011-$1.28-36.36%
2010-$2.01-36.63%
2009-$3.17-29.36%
2008-$4.48-86.74%
2007-$33.80-64.04%
2006-$93.98122.23%
2005-$42.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.63-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.21-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.28-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.35 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.87 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.54 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.07 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA